A CASE OF PRIMARY PULMONARY HYPERTENSION WITH aCL POSITIVE
Abstract
Abstract : ABSTRACT- Primary pulmonary hypertension is a diagnosis of exclusion. we present a case with aCL positive but patient not having any thromboembolic manifestations. Its a rare entity ,but if diagnosed early can be treated and prognosis is good.
Keyword :KEYWORDS- Primary pulmonary hypertension, aCL positive
Full Text:
PDFReferences
Kamashta MA, Cervera R, López-Soto A, et al. Comparison of the primary and secondary antiphospholipid syndrome
Mackworth-Young CG, Boey ML, Hull RG, et al. Pulmonary hypertension in systemic lupus erythematosus 3.Ashreson RA, Lahita RG Primary idiopathic pulmonary hypertension complicated by pulmonaryarterialthrombosis.
Yasuma K, Katsuki T, , Nakamura Y, et al. Primary antiphospholipid syndrome and pulmonary hypertension with prolonged survival. A case report.
Martínez-Guerra ML, et al. Treatment with thromboendarterectomy. De la Mata J, Gomez-Sanchez MA, Aranzana M, Gomez-Reino JJ. Longterm iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue disease.
Haworth SG. Primary pulmonary hypertension. J R Coll Physicians Lond1998;32:187.
Cucurul, L, Orriols R, Vilardell M. Tromboendarterectomía pulmonar en un paciente con
síndrome antifosfolípido primario. Med Clinc.
Sandoval J, Amigo MC, Barragan R, Izaguirre R, Reyes PA, Martínez
Guerra ML, et al. Treatment with thromboendarterectomy
Anderson EN, Ali MR. The lupus anticoagulant, pulmonary thromboembolism and fatal pulmonary hypertension. Ann Rheum .
Tam L-S, Li EK. Successful treatment with immunosupression in SLE associated with secondary antiphospholipid syndrome.
Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med.
Galiè N, Hinderliter AL, , Simonneau G, Pulido T, et al. Effects of the oral endothelinreceptor on echocardiographic and doppler measures in patients with pulmonary arterial
hypertension. J Am Coll Cardiol.
Oudiz RJ, Galiè N, Frost A, Ghofrani HA, et al. Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension. J Am Coll Cardiol. .
Simonneau G, Rubin LJ, FleminTR, Frost AE, et al. Addition of sildenafil to long-term intravenous epoprostenol therapy randomized trial. Ann Intern Med.
Galiè N, Brundage BH, Ghofran, Safdar Z, et al. Tadalafil therapy for pulmonary arterial hypertension. Circulation. [Medline].
Oudiz RJ, Farber HW. Dosing considerations in the use of intravenous prostanoids in pulmonary arterial hypertension: an experience-based review.
Shapiro SM, , Georgiou D, et al. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. J Am Coll Cardiol.
Oudiz RJ, Rubin LJ, et al. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease. Chest. . [Medline].
Simonneau Bourge RC, et al. Continuous subcutaneous
infusion of treprostinil, double-blind, randomized, trial. Am J Respir Crit Care Med
AshersonRA,HigenbottamTW, Pulmonary hypertension in a lupus clinic expierence with twenty four patients.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An initiative of The Tamil Nadu Dr M.G.R. Medical University